Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse

Area of Science:

• Lipid metabolism
• Cardiovascular research
• Molecular biology

Background:

• Cholesterol homeostasis is crucial for preventing cardiovascular and metabolic diseases.
• The ATP-binding cassette transporter A1 (ABCA1) and lecithin-cholesterol acyltransferase (LCAT) are key players in cholesterol transport.
• Understanding their combined roles is vital for developing targeted therapies.

Purpose of the Study:

• To investigate the impact of disrupting ABCA1 and LCAT on cholesterol homeostasis in mice.
• To elucidate the compensatory mechanisms involved in cholesterol transport when major pathways are impaired.

Main Methods:

• Generation of mice with targeted disruptions in Abca1 and/or Lcat genes.
• Analysis of plasma lipid profiles (HDL, LDL/VLDL) and fractional catabolic rates.
• Assessment of cholesterol accumulation in liver and peripheral tissues.
• Evaluation of HDL biogenesis and lipoprotein secretion in primary hepatocytes.
• Gene expression analysis of sterol-regulatory elements.

Main Results:

• Disruption of Abca1 and/or Lcat significantly decreased plasma HDL levels.
• Combined disruption led to reduced LDL/VLDL levels and substantial hepatic cholesterol accumulation.
• Hepatocyte cholesterol content inversely correlated with lipoprotein generation.
• Steroidogenic organs showed decreased cholesterol, while peripheral tissues showed recovery with high-cholesterol feeding.
• No significant vascular lipid deposition was observed in any genotype.

Conclusions:

• The combined deletion of ABCA1 and LCAT does not lead to severe cholesterol transport stagnation in mice.
• Compensatory pathways effectively manage cholesterol transport among organs and tissues, even with impaired major pathways.
• These findings highlight the resilience of cholesterol homeostasis and offer insights into potential therapeutic targets.